A prospective, cumulative study of testosterone-undecanoate in hypogonadal men : An Observational registry record study
Latest Information Update: 03 Nov 2020
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions; Therapeutic Use
- 25 Sep 2020 Results assessing effects of long-term therapy with testosterone on liver metabolism and MACE over 11 years in men with hypogonadism and type 2 diabetes, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 18 Mar 2019 Results assessing the effect of Testosterone Undecanoate Injections in men with Hypogonadism and Osteoporosis (n=102), presented at the 101st Annual Meeting of the Endocrine Society
- 05 Oct 2018 Results assessing long-term testosterone therapy in hypogonadal men with T2DM (n=311) presented at the 54th Annual Meeting of the European Association for the Study of Diabetes